Suppr超能文献

无法实现口服抗凝:重新审视华法林与利福平的相互作用

Inability to attain oral anticoagulation: warfarin-rifampin interaction revisited.

作者信息

Casner P R

机构信息

Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso 79905, USA.

出版信息

South Med J. 1996 Dec;89(12):1200-3. doi: 10.1097/00007611-199612000-00014.

Abstract

The warfarin-rifampin interaction is a well-described but underappreciated drug interaction. A case is reported in which therapeutic anticoagulation could not be achieved after nearly 4 weeks of warfarin therapy because of simultaneous administration of rifampin. This patient had the highest warfarin clearance ever reported in the literature. The world's literature describing warfarin-rifampin interactions for the past 32 years was reviewed to suggest guidelines for warfarin dosage when rifampin is given simultaneously.

摘要

华法林与利福平的相互作用是一种已被充分描述但未得到充分重视的药物相互作用。本文报告了一例患者,在华法林治疗近4周后,由于同时服用利福平,未能实现治疗性抗凝。该患者的华法林清除率是文献报道中最高的。回顾了过去32年描述华法林与利福平相互作用的世界文献,以提出同时给予利福平时华法林剂量的指导原则。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验